drugset / Trial / NCT01513070
A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary Stenosis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study investigates the effective power of angina pectoris after Quick-Acting Heart Reliever and isosorbide dinitrate interventing respectively the patients with moderate coronary stenosis for six months. At the same time, the studying will assess the plaque, myocardial blood-supplying,quality of life and observe the end point of the heart (including the myocardial revascularization, death and myocardial infarction). The purpose is to study the function of the blood-quickening stasis-transforming formula Quick-Acting Heart Reliever for moderate coronary stenosis lesions.
Timeline
- Start
- 2012-04
- Primary completion
- 2012-07
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Isosorbide Dinitrate | Other / unclassified | 10 mg | Oral |
| Subject | Quick-Acting Heart Reliever | Unknown | 200 mg | Oral |
| Comparator | Aspirin | Small molecule | 100 mg | Oral |